# SpyGlass Pharma, Inc.: Form SCHEDULE 13D, filed Feb 13, 2026

- Company: [SpyGlass Pharma, Inc.](/companies/sgp.md) (CIK 1778922)
- Form: SCHEDULE 13D
- Filed: 2026-02-13
- Accepted by EDGAR: Feb 13, 2026, 23:21 ET
- Period: not reported
- Accession: 0001072613-26-000183
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1778922/000107261326000183/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1778922/000107261326000183/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1778922/000107261326000183/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 13, 2026.
Source: SEC EDGAR, the filing index for accession 0001072613-26-000183. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.